CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandelblatt, J. S.
Right arrow Articles by Gold, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandelblatt, J. S.
Right arrow Articles by Gold, K.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 97-106, January 1999
© 1999 American Association for Cancer Research

Is HIV Infection a Cofactor for Cervical Squamous Cell Neoplasia?1

Jeanne S. Mandelblatt2, Peter Kanetsky, Lynne Eggert and Karen Gold

Department of Medicine, Lombardi Cancer Center [J. S. M., L. E.], Institute for Health Care Research and Policy [J. S. M.], and Department of Biostatistics and Biomathematics [K. G.], Georgetown University, Washington, DC 20007, and Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 [P. K.]

The objective of this study was to test the hypothesis that HIV interacts with human papilloma virus (HPV) to increase the odds of cervical neoplasia.

The study design was a meta-analysis using data pooled from published sources. Studies published between January 1986 and March 1998 were eligible for inclusion if they included data on neoplasia (cytology-based), HIV (defined by laboratory and/or standard clinical criteria), and HPV (assessed by PCR, Southern blot, dot-blot hybridization, or cytology of an otherwise well designed study) among nonpregnant women. Blinded data abstraction was performed independently by the investigators.

There were 15 studies that were eligible and presented data in a format that could be abstracted for analysis. Data were pooled using a Mantel-Haenszel summary odds ratio (OR); generalized estimation regression equations were used to examine independent effects of HIV and HPV. Overall, based on the Mantel-Haenszel ORs, there was a strong overall association between HPV and neoplasia [OR, 8.1; 95% confidence interval (CI), 6.5–10.1]. Stratifying by HIV status, HIV-positive women had higher odds of disease (OR, 8.8; 95% CI, 6.3–12.5) than HIV-negative women (OR, 5.0; 95% CI, 3.7–6.8). In the regression model, there was an interaction between HPV and HIV (P = 0.01); immunosuppression also tended to predict neoplasia (P = 0.058).

HIV seems to be a cofactor in the association between HPV and cervial neoplasia; this effect may vary by level of immune function. These speculations are biologically plausible. Additional data from large, well designed studies are needed to confirm these hypotheses.




This article has been cited by other articles:


Home page
Int J STD AIDSHome page
P. Lehtovirta, J. Paavonen, and O. Heikinheimo
Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women
Int J STD AIDS, January 1, 2008; 19(1): 37 - 41.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Sobhani, F. Walker, T. Aparicio, L. Abramowitz, D. Henin, A. C. Cremieux, and J. C. Soule
Effect of Anal Epidermoid Cancer-related Viruses on the Dendritic (Langerhans') Cells of the Human Anal Mucosa
Clin. Cancer Res., September 1, 2002; 8(9): 2862 - 2869.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. S. Mandelblatt, W. F. Lawrence, S. M. Womack, D. Jacobson, B. Yi, Y.-t. Hwang, K. Gold, J. Barter, and K. Shah
Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
JAMA, May 8, 2002; 287(18): 2372 - 2381.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. B. Thomas, R. M. Ray, J. Kuypers, N. Kiviat, A. Koetsawang, R. L. Ashley, Q. Qin, and S. Koetsawang
Human Papillomaviruses and Cervical Cancer in Bangkok. III. The Role of Husbands and Commercial Sex Workers
Am. J. Epidemiol., April 15, 2001; 153(8): 740 - 748.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Frisch, R. J. Biggar, and J. J. Goedert
Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
J Natl Cancer Inst, September 20, 2000; 92(18): 1500 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
I. HEARD, J.-M. TASSIE, V. SCHMITZ, L. MANDELBROT, M. D. KAZATCHKINE, and G. ORTH
Increased Risk of Cervical Disease Among Human Immunodeficiency Virus-Infected Women With Severe Immunosuppression and High Human Papillomavirus Load
Obstet. Gynecol., September 1, 2000; 96(3): 403 - 409.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. L. Ruche, B. You, V. Leroy, C. Welffens-Ekra, and F. Dabis
Correspondence re: J. S. Mandelblatt et al., Is HIV Infection a Cofactor for Cervical Squamous Cell Neoplasia? Cancer Epidemiol. Biomark. Prev., 8: 97-106, 1999
Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 729 - 730.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.